Dr. Thibodeaux presented
“Transfusion Medicine ABC's of CAR-T's:
Chimeric Antigen Receptor T Cell Therapy from the Apheresis, Blood Bank and Cellular Therapy Lab Perspective.”
Chimeric antigen receptor (CAR)-T cells are now an important component of cancer immune therapies, with three CAR-T cell products currently in use for various B cell malignancies and many more novel CART cell products under clinical development.
Dr. Thibodeaux described general CAR-T cell structure, function and indications as well as explain the role of transfusion medicine services, including apheresis, blood bank and cellular therapy laboratory, in the care of patients receiving CAR-T cell therapy
Download Handout
Chris Barron, MT (ASCP)SBB, presented
“Characterizing Unidentified Antibodies.”
Chris outlined techniques and strategies to identify rare antibodies. The talk highlighted evaluation of panreactive antibodies to determine clinical significance and impact on transfusion recommendations.
Download Handout
The second session was recorded and can be watched HERE.